3rd International Symposium on Veterinary Pharmacovigilance Berlin, 13-14th December 2010
|
|
- Catherine Cole
- 6 years ago
- Views:
Transcription
1 Veterinary Pharmacovigilance Centres: the French experience 3rd International Symposium on Veterinary Pharmacovigilance Berlin, 13-14th December 2010 Xavier Pineau*, Florence Roque*, Stéphane Queffélec*, Christophe Hugnet** *Veterinary Pharmacovigilance Centre of Lyon VetAgro Sup - Veterinary Campus of Lyon **Clin vét. des Lavandes, La Bégude de Mazenc
2 Veterinary Pharmacovigilance in France: current organisation Legislative background decree 99/553, amended 2003/760 and 2004/802 ( : effect in 2011) Included in Public health codex, Rural affairs codex Actors CA = ANMV: French Agency of VMPs, under responsibility of ANSES (French Agency for Food, Environmental and Occupational Health&Safety ) / Ministry of Agriculture, Ministry of Health Veterinary Pharmacovigilance Center (formerly 2 VPCs, currently 1) National Veterinary Pharmacovigilance Commitee Representatives of CA, VPC, veterinarians, pharmacists, pharmaceutial companies trade union Reporters MAHs Reporting Scheme adapted from Human PV 29 Regional PV Centres, National PV Committee, PV technical Committee VPC of Lyon Created 2001, but in close cooperation with National Animal Poison Control Center (CNITV) created in 1976 Contract between ANSES and VetAgro Sup (formerly Vet School of Lyon)
3 Pharmacovigilance reporting: French legislation Veterinarians (and pharmacists) (Art. R of public health codex) must report immediately to a Veterinary Pharmacovigilance Centre (VPC) any serious or unexpected suspected adverse reaction to a Veterinary Medicinal Product (VMP), or to a human medicine in animal (used under the «cascade») ; regardless VMP prescribed or not by reporter, and regardless adverse reaction observed directly by vet or not may report other adverse events (non-serious SAR, off-label use, withdrawal period issue, lack of expected efficacy) Health care professionals may report suspected adverse reaction to a VMP to a VPC Poison Control Centres and (human) Regional Pharmacovigilance Centres must report immediately to a VPC any suspected adverse reaction to a Veterinary Medicinal Product (VMP) occuring in humans
4 the French Veterinary Pharmacovigilance Reporting Scheme Health Care Professionals Regional Pharmacovigilance Centres Poison Control Centres e-reporting (web) Veterinarians (Pharmacists) ANMV SARs PSURs MAH National Committee of Veterinary Pharmacovigilance information -reports -newsletter National Marketing Authorisation Committee Corrective measures -SPC modifications -MA suspension
5 VPC: an interactive interface between reporters and CA (1) 1/ phone contact (85%) round the clock hotline (shared with Poison Control Centre) immediate answer to reporter first estimation of causality therapy, prognosis Vets Physicians Pharmacists also questions related to asymptomatic (accidental) exposures in animals/humans drug use in particular species, breed, physiological status, interaction
6 VPC: an interactive interface between reporters and CA(2) Vets Physicians Pharmacists 2/ in writing spontaneous report form (15%) report form received after phone contact (46% returned back) VPC letter to the reporter, including: final VPC causality assessment comment exception: BTV cases managed directly by the Agency
7 VPC: an interactive interface between reporters and CA(3) Vets Physicians Pharmacists 3/ VPC and the Agency report form (from phone call/written report) recorded in database (Sentinelvet ) causality assessment performed (literature, comparison with db) electronic reporting to the Agency (secure web) serious SAR within 10 days non-serious SAR within 3 months
8 VPC: inside Veterinary Campus round the clock service: involvement of selected trained students practical teaching exercise: students are faced «real-life cases» learn autonomy (senior pharmacovigilance vet always available) know-how (reporting, bibliographic search) highlighted in international audits of the Vet Campus AEEV AVMA first line for promoting pharmacovigilance for future vets in cooperation with teachers basic course (all students) end-study (e.g horse medicine)
9 graduation veterinary thesis VPC: inside Veterinary Campus (2) Delhaye D. Side effects and poisoning due to the use of medicines containing permethrin on cats. Epidemiological study (2008): (in French) Gedoux F. Problem of drug residues in food of vultures, especially anti-inflammatory drugs, antibiotics and euthanasia drugs used in livestock (2010) (in French) postgraduate education : Pharmacovigilance-Toxicovigilance Master to be conducted again? cooperation with colleagues of various teaching/research areas (inside Campus / other Vet Schools) Several teachers/researchers involved in National PV Committee over the last 9 years Pr Keck (Lyon), former Chairman Dr Alvinerie (Toulouse), current Chairman helpful for scientific evaluation, where necessary e.g toxicological analysis lab of Lyon, Pharmacology Unit of Toulouse provide some valuable case reports e.g Cardiology Unit of Alfort Vet School
10 VPC: key figures. 1/ reporting way, yearly distribution BTV I AsE WR* NV-tel* V-tel* Most reports by telephone over 85% (except BTV) Vets: near 90% of reports; pharmacists 0.3%; owner 6.5% Continuous increase until plateau phase BTV excepted V-tel*: phone call, veterinary reporters (BTV excluded) NV-tel*: phone call, non-veterinary reporters (BTV excluded): owner, physician, PCC WR*: spontaneous written report (BTV excluded) AsE: Asymptomatic exposure I: general information BTV: Bluetongue vaccination adverse events
11 VPC: key figures. 2/ Species - yearly distribution Other Rabbit Ovine Equine Human Bovine Canine Feline Companion animals: over 85% Livestock increase of ruminants: BTV only (cattle 3% for other classes of VMPs) pigs and poultry: negligible numbers
12 VPC: key figures. 3/ VMP category - yearly distribution (ATC-vet) Others Dermatologicals&Sensory organs Hormones&Corticoids Alimentary Musculo-skeletal Neurological Antibiotic Vaccine Internal Parasiticide Endectocide Majority of parasiticides 30-60% decrease of external parasiticides (mainly: permethrin spot in cats) Vaccines increase = BTV vaccines other vaccines#3-5% External Parasiticide
13 VPC: involved in national committees National Veterinary Pharmacovigilance Committee 3 vets of VPC members of this Committee ( ) , the Committee released 19 public reports (in French) ce/rubrique%20lettre.htm Summarized in 7 PV newsletters sent to all vets and pharmacists Toxicovigilance network (human safety scheme) contribution to reports e.g clenbuterol misuse in humans (2010) buterol_2010.pdf (in French)
14 VPC: international cooperation VPC: participation to EMA-PhVWP 1 vet as expert ( ) contributions regarding causality assessment, signal detection, Veddra VPC: informal contacts with other countries Switzerland Italy Spain
15 Advantages of the French Reporting System / VPC Advantages for Reporters round the clock service for emergency situations (e.g overdose): availability pharmacovigilance reporting as easy as a phone call other options available (mail, , fax, and since early 2010 web reporting directly to the ANMV) feed-back tailored answer (oral/in writing) newsletter from Committee Advantages for Reporting scheme Direct contact increases quality of data (spontaneous written reports usually less informative)
16 Drawbacks of the French Reporting System / VPC Cost round the clock service 3 full-time vets (cost supported by ANSES) 0.5 secretary (cost supported by ANSES) 0.75 librarian (cost supported by ANSES) 45 students (equivalent to 1 full time vet; cost supported by Poison Control Centre) at start (2001) network of 2 VPCs Dec 2008,VPC of Nantes closed
17 Perspectives of the French Pharmacovigilance Scheme 2011 Committee of Marketing Autorisation of VMPs and Veterinary Pharmacovigilance Committee merge into a Committee of VMPs (come into effect January 2011) 5 representatives of CA, 18 nominated members (pharmacologists, vets, ) expected benefit: quicker implementation of recommendations (e.g modifications of SPC) Network of «sentinel veterinarians» in the field of pharmacovigilance, for targeted surveillance (e.g for BTV vaccines or any rising issue) Postmarketing studies case-control studies (e.g mammary tumours and progestins; report of the PV Committee estimated a high level of underreporting)
18 Thank you for your attention Vielen Dank zu Cornelia Ibrahim und zum BVL
PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections London, 20 June 2003 PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS Meeting of 17 to 19 June
More informationReflection paper on promotion of pharmacovigilance reporting
13 July 2017 EMA/CVMP/PhVWP/390033/2014-Rev.1 Committee for Medicinal Products for Veterinary Use (CVMP) Reflection paper on promotion of pharmacovigilance reporting Draft agreed by CVMP Pharmacovigilance
More informationPresentation of ANSES
Presentation of ANSES French Agency for Food, Environmental and Occupational Health & Safety Role and activities 20 november 2015 1 Creation and origins ANSES was created on 1 st of July 2010 under the
More informationStandard operating procedure
Standard operating procedure Title: Annual review of VeDDRA list to be used in EudraVigilance Veterinary Status: PUBLIC Document no.: SOP/V/4019 Lead author Approver Effective date: 15-MAY-15 Name: Raquel
More informationRecommendation for the basic surveillance of Eudravigilance Veterinary data
1 2 3 25 May 2010 EMA/CVMP/PhVWP/471721/2006 Veterinary Medicines and Product Data Management 4 5 6 Recommendation for the basic surveillance of Eudravigilance Veterinary data Draft 7 Draft agreed by Pharmacovigilance
More informationPRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 12 to 14 October 2004
European Medicines Agency Veterinary Medicines and Inspections London, 15 October 2004 EMEA/CVMP/973/04 PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 12 to 14 October 2004
More informationGiles Davis., BVSc., GPCertSAP,, MRCVS
VETERINARY PHARMACOVIGILANCE IN THE UK Giles Davis., BVSc., GPCertSAP,, MRCVS Head of Pharmacovigilance Unit, Veterinary Medicines Directorate, Woodham Lane, New Haw, Addlestone Surrey, KT15 3LS, United
More informationVeterinary Pharmacovigilance
Veterinary Pharmacovigilance The French pharmacovigilance system and the main events of 2012 in terms of adverse reactions Annual Report October 2013 Scientific Edition Veterinary Pharmacovigilance The
More informationFocus group on promotion of PhV for food producing animals MAH view. IFAH-Europe Tony Simon 23rd November 2016
Focus group on promotion of PhV for food producing animals MAH view IFAH-Europe Tony Simon 23rd November 2016 SCOPE Veterinary Medicinal Products Regulated by EMA or EU Member State (MS) Regulatory Agencies
More informationPublic bulletin - Veterinary pharmacovigilance 2010
10 February 2011 EMA/CVMP/PhVWP/44873/2011 Committee for Medicinal Products for Veterinary Use (CVMP) 1. Introduction This is the 8 th bulletin from the European Medicines Agency on veterinary pharmacovigilance
More informationPRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 13 to 15 July 2004
European Medicines Agency Veterinary Medicines and Inspections London, 16 July 2004 EMEA/CVMP/713/04/Rev 1 PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 13 to 15 July 2004
More informationVICH GL30 on pharmacovigilance of veterinary medicinal products: controlled list of terms
12 December 2013 EMA/CVMP/VICH/647/2001 Committee for Medicinal Products for Veterinary Use (CVMP) VICH GL30 on pharmacovigilance of veterinary medicinal products: controlled list of terms Adoption by
More informationInternational Harmonisation in the Field of Pharmacovigilance from an OIE perspective
Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products BP 90203-35302 FOUGERES CEDEX, FRANCE elisabeth.begon@anses.fr International Harmonisation in the Field of Pharmacovigilance from an
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency Veterinary Medicines and Inspections London, 24 February 2009 EMEA/CVMP/PhVWP/253196/2008 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE EMEA PUBLIC BULLETIN 2008 ON VETERINARY
More informationOpinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004
11 December 2014 EMA/CVMP/761582/2014 Veterinary Medicines Division EMEA/V/A/107 Opinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE. Monthly Report of Application Procedures, Guidelines and Related Documents
European Medicines Agency Veterinary Medicines and Inspections London, 30 November 2007 Doc. Ref. EMEA/571778/2007 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Monthly Report of Application Procedures,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BLUEVAC BTV8 suspension for injection for cattle and sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE. Monthly Report of Application Procedures, Guidelines and Related Documents
European Medicines Agency Veterinary Medicines and Inspections London, 30 April Doc. Ref. EMEA/284966/ COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Monthly Report of Application Procedures, Guidelines
More informationAssessment of compliance of current legislation: Veterinary Products Act
of compliance of current legislation: Veterinary Products Act Dr Stuart A. Slorach Chairman, OIE Animal Production Food Safety Working Group Training seminar on veterinary legislation, Gaborone, 2011 1
More informationFurther memorandum submitted by the Department for Environment, Food and Rural Affairs
Further memorandum submitted by the Department for Environment, Food and Rural Affairs Follow-up to the evidence session on 5 November 2008: [Bee research] I am writing in response to your letter of 10
More informationLegislation on Veterinary Medicinal Products (VMPs) and legal status of relevant VMPs for anesthesia of finfish
Legislation on Veterinary Medicinal Products (VMPs) and legal status of relevant VMPs for anesthesia of finfish Anesthesia of Big Research Fish Bergen, March 6th. 2018 Tonje Høy, DVM, PhD Scientific director,
More informationScientific Discussion post-authorisation update for Rheumocam extension X/007
5 May 2011 EMA/170257/2011 Veterinary Medicines and Product Data Management Scientific Discussion post-authorisation update for Rheumocam extension X/007 Scope of extension: addition of 20 mg/ml solution
More informationDraft ESVAC Vision and Strategy
1 2 3 7 April 2016 EMA/326299/2015 Veterinary Medicines Division 4 5 6 Draft Agreed by the ESVAC network 29 March 2016 Adopted by ESVAC 31 March 2016 Start of public consultation 7 April 2016 End of consultation
More informationOIE Standards for: Animal identification and traceability Antimicrobials
OIE Standards for: Animal identification and traceability Antimicrobials OIE regional seminar on food safety Singapore, 12-14 October 2010 Yamato Atagi 1 Deputy Head, International Trade Department, OIE
More informationDr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE
Dr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP 90203-35302 FOUGERES CEDEX, FRANCE gerard.moulin@anses.fr Introduction to the working sessions Need for a good
More informationCouncil of the European Union Brussels, 13 June 2016 (OR. en)
Council of the European Union Brussels, 13 June 2016 (OR. en) 9952/16 SAN 241 AGRI 312 VETER 58 NOTE From: To: General Secretariat of the Council Council No. prev. doc.: 9485/16 SAN 220 AGRI 296 VETER
More informationScientific and technical support NOTE of the French Agency for Food, Environmental and Occupational Health & Safety
The Director General Maisons-Alfort, 18 August 2017 Scientific and technical support NOTE of the French Agency for Food, Environmental and Occupational Health & Safety on "the maximum concentration of
More informationResults of the questionnaire on Veterinary Medicinal Products in the Middle East Damascus, Syria, 2-4 December 2009
Results of the questionnaire on Veterinary Medicinal Products in the Middle East Damascus, Syria, 2-4 December 2009 Dr Pierre Primot OIE for the Middle East Purpose of the Questionnaire Public policies
More informationThe impact of Good Veterinary Services Governance (GVSG) on the control over Veterinary Medicinal Products (VMP s)
The impact of Good Veterinary Services Governance (GVSG) on the control over Veterinary Medicinal Products (VMP s) The evaluation of Good Veterinary Governance with the OIE Performance of Veterinary Services
More informationOlivier FAUGERE DVM - Director National School for Veterinary Services - ENSV
Olivier FAUGERE DVM - Director National School for Veterinary Services - ENSV An example of collaboration between a veterinary education establishment, national veterinary services and veterinary associations
More informationDiclofenac in Europe an update
Diclofenac in Europe an update Diclofenac: non-steroidal anti-inflammatory substance Vet diclofenac caused 95-99% decline in Indian Gyps vultures in 20 years Vet diclofenac in Europe Safe alternative exists
More informationSales survey of Veterinary Medicinal Products containing Antimicrobials in France
Sales survey of Veterinary Medicinal Products containing Antimicrobials in France - 2009 February 2011 Édition scientifique Sales survey of Veterinary Medicinal Products containing Antimicrobials in France
More informationVeterinary pharmacovigilance 2014
2 March 2015 EMA/CVMP/793263/2014 Committee for Medicinal Products for Veterinary Use (CVMP) Public bulletin 1. Executive Summary This public bulletin is aimed at informing veterinarians and the public
More informationPhysician Veterinarian Do you have the Bayer Spirit?
CropScience HealthCare MaterialScience Business Services Industry Services Technology Services www.mybayerjob.com Physician Veterinarian Do you have the Bayer Spirit? Research and Development, Occupational
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COXEVAC suspension for injection for cattle and goats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationOIE standards on the use of antimicrobials and antimicrobial resistance monitoring
Caroline Planté Sub-Regional Representation in Brussels OIE standards on the use of antimicrobials and antimicrobial resistance monitoring OIE Regional Seminar on Food Safety Sofia, Bulgaria, 22-24 April
More informationCommittee for Medicinal Products for Veterinary Use (CVMP) Meeting of July 2016
15 July EMA/CVMP/454098/ Press Office Press release Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 12-14 July The Committee elected Helen Jukes from the United Kingdom as its vice-chair
More informationCommittee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018
7 December 2017 Committee for Medicinal Products for Veterinary Use (CVMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018 Chairpersons Chair: D. Murphy Status Adopted in December
More informationVETERINARY MEDICINE-VM (VM)
Veterinary Medicine-VM (VM) 1 VETERINARY MEDICINE-VM (VM) Courses VM 603 Veterinary Science: Research and Methods Credit: 1 (1-0-0) Course Description: Conduct of responsible research, contributions of
More information21st Conference of the OIE Regional Commission for Europe. Avila (Spain), 28 September 1 October 2004
21st Conference of the OIE Regional Commission for Europe Avila (Spain), 28 September 1 October 2004 Recommendation No. 1: Recommendation No. 2: Recommendation No. 3: Contingency planning and simulation
More informationQuality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products
Quality of Veterinary Medicinal Products How to ensure the quality of Veterinary Medicinal Products Jean-Pierre Orand Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products Jean-pierre.orand@anses.fr
More informationAction for Combatting AMR in Veterinary Sector
Hirofumi Kugita OIE Regional Representative for Asia and the Pacific Action for Combatting AMR in Veterinary Sector AMR Symposium, 1 st G7 CVO Forum 24 November 2016 * Tokyo, Japan OIE: An intergovernmental
More informationVeterinary pharmacovigilance 2016
16 February 2017 EMA/568976/2016 Committee for Medicinal Products for Veterinary Use Public bulletin 1. Executive Summary This public bulletin is aimed at informing veterinarians and the public of the
More informationPRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 7-9 November 2006
European Medicines Agency London, 10 November 2006 EMEA/CVMP/430553/2006-Rev.1 PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 7-9 November 2006 CVMP Opinions on Veterinary
More informationWorkshop on Strengthening livestock health and Veterinary Services. Kiev, 2-3 November 2010 TAIEX, AGR 42266
Workshop on Strengthening livestock health and Veterinary Services Kiev, 2-3 November 2010 TAIEX, AGR 42266 1 Session III: Overview Veterinary Medicines Legislation in the EUROPEAN UNION Nancy De Briyne
More informationSales survey of Veterinary Medicinal Products containing Antimicrobials in France Volumes and estimated exposure of animals to antimicrobials
Sales survey of Veterinary Medicinal Products containing Antimicrobials in France - 2013 Volumes and estimated exposure of animals to antimicrobials October 2014 Scientific Edition Sales survey of Veterinary
More informationLegislation, Registration and Control Procedures for Veterinary Medicinal Products in the European Union
Legislation, Registration and Control Procedures for Veterinary Medicinal Products in the European Union David Mackay European Medicines Agency (EMEA) London, UK Legal Framework Medicines control within
More informationOIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I
Dr Elisabeth Erlacher-Vindel Head of the Antimicrobial Resistance and Veterinary Products Department OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I 2nd
More informationAgvet Chemicals Task Group Veterinary Prescribing and Compounding Rights Working Group
Agvet Chemicals Task Group Veterinary Prescribing and Compounding Rights Working Group Submission from the Australian Veterinary Association Ltd www.ava.com.au The Australian Veterinary Association Limited
More informationAmbassade de France en Chine. The French Food Safety System
Ambassade de France en Chine The French Food Safety System French-German food safety seminar Beijing, 6.11.2015 The French Farm 500 000 holdings 19.1 million head 24.5 million tonnes Plant: 38 000 M Animal:
More informationPrudent use of antimicrobial agents Dairy Sector Initiatives. Robin Condron Dairy Australia
Prudent use of antimicrobial agents Dairy Sector Initiatives Robin Condron Dairy Australia INTERNATIONAL DAIRY FEDERATION Our mission To represent the dairy sector as a whole at international level, by
More informationHighlights on Hong Kong Strategy and Action Plan on Antimicrobial Resistance ( ) (Action Plan)
香港藥學會 The Pharmaceutical Society of Hong Kong Kowloon G.P.O. Box 73552, Yau Ma Tei, Kowloon, Hong Kong Society s Fax: (852) 2376-3091 E-mail: pharmacist@pshk.hk Websites: http://pshk.hk Highlights on Hong
More informationPRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency London, 14 March 2008 EMEA/CVMP/96162/2008 PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 11-13 March 2008 CVMP Opinions on Veterinary Medicinal
More informationVeterinarians and Bee Health involvement taking France as an example
Veterinarians and Bee Health involvement taking France as an example Nicolas Vidal-Naquet, DVM DIE Beekeeping Honey Bee Pathology GTV Beekeeping commission www.apivet.eu December 2009 1 Summary History
More informationContents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department
Contents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department Regional Seminar for National Focal Points for Veterinary Products, Maputo, 3 5 December 2013
More informationActions for combatting Antimicrobial Resistance (AMR)
Symposium on the OIE s activities and Japan inviting Dr. Monique Eloit, Director General of OIE Date: 24 March 2017 Venue: Yayoi Auditorium Ichijo Hall, The University of Tokyo Actions for combatting Antimicrobial
More informationBetter Training for Safer Food
Better Training for Safer Food Initiative Susanne Münstermann Better Training for Safer Food is an initiative of the European Commission aimed at organising an EU training strategy in the areas of food
More informationSpecificities of Products for Veterinary Use
Specificities of Products for Veterinary Use The EU medicines regulatory system and the European Medicines Agency: an introduction for international regulators and non-governmental organisations Presented
More informationStandard operating procedure
Standard operating procedure Title: Procedure for provision of scientific recommendation on classification of ATMPs Status: PUBLIC Document no.: SOP/H/3309 Lead author Approver Effective date: 13-JUN-16
More informationHMA-V Action plan on antimicrobial issues Version for publication (27 January 2011)
HMA-V Action plan on antimicrobial issues Version for publication (27 January 2011) 1. Introduction Antimicrobial resistance (AMR) is considered to be a major global public health concern and a potential
More informationEFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA
EFSA s activities on Antimicrobial resistance in the food chain Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA EFSA IS The reference body for risk assessment of food and feed in the European Union. Its
More informationAll medicinal products (for human and veterinary use) are regulated under the single Pharmaceutical Act.
1 2 All medicinal products (for human and veterinary use) are regulated under the single Pharmaceutical Act. The Act and the subsequent Cabinet Ordinance provide higher rules applicable for both human
More informationAntimicrobial Resistance Actions undertaken by the Anses (alternatives to AM)
Antimicrobial Resistance Actions undertaken by the Anses (alternatives to AM) Charlotte Grastilleur, risk assessment departement, deputy head (food and health) Mapping of structures involved at Anses Coordination
More informationAntimicrobial resistance in food safety perspective - current situation in Croatia
Antimicrobial resistance in food safety perspective - current situation in Croatia Ivana Lohman Janković, DVM Ministry of Agriculture, Fisheries and Rural Development Veterinary Directorate Human and Veterinary
More information08/09/2009. Constraints for the livestock industry in Zambia. Veterinary Education and Curriculum Development: Zambia (Lusaka)
Veterinary Education and Curriculum Development: Zambia (Lusaka) Aaron S. Mweene, PhD Dean, University of Zambia Constraints for the livestock industry in Zambia Zambia supports over 2 million cattle,
More informationRegional Analysis of the OIE PVS Missions in South-East Asia with a focus on APFS
Regional Analysis of the OIE PVS Missions in South-East Asia with a focus on APFS Regional Seminar for OIE National Focal Points for Animal Production Food Safety Hanoi, Vietnam, 24-26 June 2014 Dr Agnes
More informationinternational news RECOMMENDATIONS
The Third OIE Global Conference on Veterinary Education and the Role of the Veterinary Statutory Body was held in Foz do Iguaçu (Brazil) from 4 to 6 December 2013. The Conference addressed the need for
More informationOIE GLOBAL DATABASE ON AMU IN ANIMALS
OIE GLOBAL DATABASE ON AMU IN ANIMALS The database contributes to the Global Action Plan and will allow to establish baseline information on the use of antimicrobials in animals. The information gathered
More informationAn agency of the European Union
An agency of the European Union Human medicines in 23 Research and development 473 overall number of scientific advice and protocol assistance requests received in 23
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BTVPUR AlSap 1 suspension for injection for sheep and cattle. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose
More informationMonthly report on application procedures, guidelines and related documents for veterinary medicines
2 June 7 EMA/3737/7 Veterinary Medicines Division Monthly report on application procedures, guidelines and related documents for May 7 This report, which is updated every month, provides current information
More informationFACULTAT DE VETERINÀRIA DE BARCELONA
FACULTAT DE VETERINÀRIA DE BARCELONA Evaluation Report for EAEVE revisit March 2007 UNIVERSITAT AUTÒNOMA DE BARCELONA The expert group from EAEVE-FVE visited the Veterinary Faculty of the Autonomous University
More informationANNUAL DECLARATION OF INTERESTS (ADoI)
ANNUAL DECLARATION OF INTERESTS (ADoI) (Please note that high quality of scientific expertise is by nature based on prior experience and that therefore having an interest does not necessarily mean having
More informationCODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP Adopted 2005
CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP 61-2005 Adopted 2005 CAC/RCP 61-2005 2 1. INTRODUCTION 2. AIMS AND OBJECTIVES 3. RESPONSIBILITIES OF THE REGULATORY AUTHORITIES
More informationProposal for a Regulation on veterinary medicinal products
Proposal for a Regulation on veterinary medicinal products European Commission Directorate Health and Food Safety Health systems and products Medicinal products - quality, safety and efficacy 24 February
More informationEMA advice on the impact of the use of antibiotics on public and animal health: Potential impact on the authorisation of antimicrobials
EMA advice on the impact of the use of antibiotics on public and animal health: Potential impact on the authorisation of antimicrobials Helen Jukes, CVMP member EMA/IFAH-Europe Info Day, 12 March 2015
More informationCOUNTRY REPORT THAILAND. Sasi Jaroenpoj Department of Livestock Development
COUNTRY REPORT THAILAND Sasi Jaroenpoj Department of Livestock Development 1 DLD Organization Chart Director General Senior Veterinary and Livestock Experts Deputy DG (Animal Health) Deputy DG (Food Safety)
More informationOverview of the OIE PVS Pathway
Overview of the OIE PVS Pathway Regional Seminar for OIE National Focal Points for Animal Production Food Safety Hanoi, Vietnam, 24-26 June 2014 Dr Agnes Poirier OIE Sub-Regional Representation for South-East
More informationAUDIT REPORT. Auditor(s) UFPAL
National Veterinary Research Institute AUDIT REPORT Area being audited 4.6. Purchasing services and supplies Auditor(s) UFPAL Date/Time 22/07/2015 Contact: UFPAL Aleja Królewska 17 24-100 Puławy Phone
More informationStephane MARTINOT Past dean of VetAgro Sup (Lyon, France) Challenges for accreditation: how to harmonise mechanisms at the global level and how to
Stephane MARTINOT Past dean of VetAgro Sup (Lyon, France) Challenges for accreditation: how to harmonise mechanisms at the global level and how to adopt OIE guidelines in the mechanisms 1761: the first
More informationResponsible use of antimicrobials in veterinary practice
Responsible use of antimicrobials in veterinary practice Correct antimicrobial: as little as possible, as much as necessary This document provides more information to accompany our responsible use of antimicrobials
More informationIllegal veterinary drugs. How to ensure the quality and traceability of Veterinary Medicinal Products
Illegal veterinary drugs How to ensure the quality and traceability of Veterinary Medicinal Products Catherine LAMBERT Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products catherine.lambert@anses.fr
More informationSales survey of veterinary medicinal products containing antimicrobials in France in Annual report
Sales survey of veterinary medicinal products containing antimicrobials in France in 2016 Annual report October 2017 Scientific edition Sales survey of veterinary medicinal products containing antimicrobials
More informationThe European Union Reference Laboratories network
The European Union Reference Laboratories network Structure, objectives and responsibilities of the European reference laboratory system responsibilities in case of a crisis Frank Swartenbroux European
More informationNASH Analysis Lab. Report of the audit. Prepared by: NASH Analysis Lab. CEO: Ni Ni Win. Quality manager: AgnieszkaPaszkowska
Report of the audit Prepared by: NASH Analysis Lab CEO: Ni Ni Win Quality manager: AgnieszkaPaszkowska Lab manager: Héloïse Besson Lab technician: Sylvestre Pagkeu Organization to be assessed: The National
More informationOIE stray dog control standards and perspective. Dr. Stanislav Ralchev
OIE stray dog control standards and perspective Dr. Stanislav Ralchev Background In May 2006, the OIE recognised the importance of providing guidance to members on humane methods of stray dog population
More informationSupport for OIE Member Countries OIE PVS / Gap Analysis, Reference Laboratories and twinning programmes
OIE Focal Point Seminar on Veterinary Products Vienna, Austria, November 20-22 2012 Support for OIE Member Countries OIE PVS / Gap Analysis, Reference Laboratories and twinning programmes N. Leboucq OIE
More informationStratégie et action européennes
Résistance aux antibiotiques : une impasse thérapeutique? Implications nationales et internationales Stratégie et action européennes Dominique L. Monnet, Senior Expert and Head of Disease Programme Antimicrobial
More informationChina Training Seminar on the OIE PVS Tool for East Asia Seoul, Republic of Korea, April 2016
National Veterinary Services- General Background Information China Training Seminar on the OIE PVS Tool for East Asia Seoul, Republic of Korea, 26 28 April 2016 1 Outline 1. Veterinary Services Background
More informationEPAR type II variation for Metacam
23 June 2011 EMA/674662/2011 International Non-proprietary Name: Meloxicam Procedure No. EMEA/V/C/033/II/084 EU/2/97/004/026, 33-34 Scope: Type II Addition of indication for cats Page 1/6 Table of contents
More informationNational Action Plan development support tools
National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan
More informationSurveillance of animal brucellosis
Surveillance of animal brucellosis Assoc.Prof.Dr. Theera Rukkwamsuk Department of large Animal and Wildlife Clinical Science Faculty of Veterinary Medicine Kasetsart University Review of the epidemiology
More informationAnnual Report in accordance with Article 13, paragraph 4
PROTOCOL II ON PROHIBITIONS OR RESTRICTIONS ON THE USE OF MINES, BOOBY-TRAPS AND OTHER DEVICES AS AMENDED ON 3 MAY 1996 ANNEXED TO THE CONVENTION ON PROHIBITIONS OR RESTRICTIONS ON THE USE OF CERTAIN CONVENTIONAL
More informationREZIDUE CONTROL IN SERBIA & MRLs
REZIDUE CONTROL IN SERBIA & MRLs Presented by: Slobodan ŠIBALIC,DVM and Tamara BOŠKOVIĆ,DVM, MAFWM-Veterinary Directorate Legislation In-Force Law on Veterinary Matters (OG RS, No. 91/2005 + amend. OG
More informationBTSF. Better Training for Safer Food Initiative. Antimicrobial Resistance One Health approach MEASURE UNITS
Better Training for Safer Food Initiative Antimicrobial Resistance One Health approach MEASURE UNITS BTSF This presentation is delivered under contract with the Consumers, Health, Agriculture and Food
More informationCOMMISSION. (Text with EEA relevance) (2009/712/EC)
19.9.2009 Official Journal of the European Union L 247/13 COMMISSION COMMISSION DECISION of 18 September 2009 implementing Council Directive 2008/73/EC as regards Internet-based information pages containing
More informationOIE Collaborating Centres Reports Activities
OIE Collaborating Centres Reports Activities Activities in 2016 This report has been submitted : 2017-01-20 17:44:12 Title of collaborating centre: Maladies infectieuses de la reproduction en Europe Address
More informationIntroduction SEAVDRAC. 23 October Prof G E Swan. Southern and Eastern African Veterinary Drug Regulatory Affairs conference
23 October 2010 Prof G E Swan 1 Introduction Ghana; Kenya; Mauritius; Mozambique; Namibia; Nigeria; South Africa; Tanzania; Uganda; Zimbabwe Southern and Eastern African Veterinary Drug Regulatory Affairs
More informationReview of Legislation for Veterinary Medicinal Products Version 2
Position Paper Brussels, 13 April 2012 Review of Legislation for Veterinary Medicinal Products Version 2 Directive 2004/28 entered into force on 1 st May 2004, introducing many improvements for the transparent
More informationDr A T Sigobodhla. Regional Workshop for OIE National Focal Points for Veterinary Products (Cycle V): Ezulwini, Swaziland, 6-8 December 2017
Follow up of recommendations of the joint GALVmed / OIE workshop on harmonisation of the registration of veterinary medicinal products in the SADC region: Perspective of the NRAs Regional Workshop for
More information